PTHS

Pelthos Therapeutics Inc.$27.50-1.22 (-4.23%)

Prev Close$28.72·MCap$15.4M·P/E—·Vol1.5K·Yield—

▲

Buys (12M)

$0.00

▼

Sells (12M)

$377.7K

◆

Net Activity

Net Seller

$377.7K

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Pelthos Therapeutics Inc. (PTHS) has been exclusively selling, with 0 insider purchases totaling $0.00 and 6 insider sales totaling $377.7K. The most recent insider transaction was by Francis Knuettel II (officer: CFO, Treas & Secty), who sold $40.3K worth of shares on May 26, 2026. Pelthos Therapeutics Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $15.4M.

PTHS Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
May 26, 2026	Francis Knuettel II	officer: CFO, Treas & Secty	Sell	1,500	$26.84	$40.3K	11,316
Apr 6, 2026	Friedberg Ezra M	director	Sell	558	$20.92	$11.7K	82,292
Apr 6, 2026	Greenleaf Peter	director	Sell	797	$20.92	$16.7K	25,058
Apr 6, 2026	Malamut Richard	director	Sell	590	$20.92	$12.3K	27,702
Apr 6, 2026	Pauls Matthew	director	Sell	786	$20.92	$16.4K	15,521
Nov 25, 2025	Friedberg Ezra M	Director	Sell	10,000	$28.03	$280.3K1.5% OS	0
Sep 16, 2024	Francis Knuettel II	CEO, Pres., CFO, Treas & Secty	Buy	5,200	$0.97	$5.0K0.8% OS	547,710
Sep 16, 2024	Malamut Richard	Director	Buy	10,400	$0.94	$9.8K1.6% OS	91,565
Sep 12, 2024	Francis Knuettel II	CEO, Pres., CFO, Treas & Secty	Buy	12,000	$0.91	$11.0K1.9% OS	542,510

PTHS Insider Buying Activity

The following table shows recent insider purchases of Pelthos Therapeutics Inc. (PTHS) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Sep 16, 2024	Francis Knuettel II	CEO, Pres., CFO, Treas & Secty	Buy	5,200	$0.97	$5.0K0.8% OS	547,710
Sep 16, 2024	Malamut Richard	Director	Buy	10,400	$0.94	$9.8K1.6% OS	91,565
Sep 12, 2024	Francis Knuettel II	CEO, Pres., CFO, Treas & Secty	Buy	12,000	$0.91	$11.0K1.9% OS	542,510

PTHS Insider Selling Activity

The following table shows recent insider sales of Pelthos Therapeutics Inc. (PTHS) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
May 26, 2026	Francis Knuettel II	officer: CFO, Treas & Secty	Sell	1,500	$26.84	$40.3K	11,316
Apr 6, 2026	Friedberg Ezra M	director	Sell	558	$20.92	$11.7K	82,292
Apr 6, 2026	Greenleaf Peter	director	Sell	797	$20.92	$16.7K	25,058
Apr 6, 2026	Malamut Richard	director	Sell	590	$20.92	$12.3K	27,702
Apr 6, 2026	Pauls Matthew	director	Sell	786	$20.92	$16.4K	15,521
Nov 25, 2025	Friedberg Ezra M	Director	Sell	10,000	$28.03	$280.3K1.5% OS	0